0001438133-21-000199.txt : 20211103
0001438133-21-000199.hdr.sgml : 20211103
20211103165347
ACCESSION NUMBER: 0001438133-21-000199
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211101
FILED AS OF DATE: 20211103
DATE AS OF CHANGE: 20211103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBERTSON REBECCA B
CENTRAL INDEX KEY: 0001201585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 211376265
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
wf-form4_163597280304758.xml
FORM 4
X0306
4
2021-11-01
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001201585
ROBERTSON REBECCA B
C/O TANDEM DIABETES CARE, INC.
11075 ROSELLE STREET
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2021-11-01
4
M
0
1108
34
A
1500
D
Common Stock
2021-11-01
4
S
0
1222
135.64
D
278
D
Common Stock
2021-11-01
4
S
0
278
136.35
D
0
D
Stock Option
34.0
2021-11-01
4
M
0
1108
34
A
Common Stock
1108.0
34892
D
Represents shares of common stock received upon exercise of a stock option award.
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $135.05 to $136.04. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $136.19 to $136.53. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
The expiration date for these options is 10 years from the date of grant.
s/ David B. Berger, Attorney-in-Fact for Rebecca B. Robertson
2021-11-03